Genome Nation

Researchers perform whole-genome sequencing on roughly 1 percent of the Icelandic population.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, AKIGKAWhole-genome data from more than 2,600 Icelanders, published this week (March 25) in a series of papers in Nature Genetics, offer unprecedented insight into the diversity of humans. A team led by Decode Genetics’s Kári Steffánsson, identified genes related to Alzheimer’s and other diseases, dated the last common father to around 239,000 years ago, and found the prevalence of having a loss-of-function gene to be near 8 percent of the population, according to BioIT World.

Daniel MacArthur of Massachusetts General Hospital in Boston and the Broad Institute told Science the studies were “an amazing piece of work” that “was impossible five years ago.”

As MIT Technology Review noted, Decode has enough genetic data on Icelandic men and women to extrapolate the presence of, say, a harmful mutation in others who have not contributed their genomes for research. “We could in Iceland, at the push of a button, find all women with a mutation in the BRCA2 gene,” Stefánsson told Tech Review. “It is one tiny little example of what you can do. You can use this in preventive medicine like never before.”

That ability opens up new ethical territory. “Do you have the right to fiddle with people’s lives on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies